Shares of TransMedics Group (NASDAQ: TMDX) were tanking 14.3% lower as of 10:46 a.m. ET on Friday. The big sell-off came ...
In diabetes care, the MiniMed 780G insulin pump system uses AI algorithms to predict and adjust insulin delivery based on ...
In this video, I will talk about TransMedics (NASDAQ: TMDX) and the recent short-seller report. Watch the short video to learn more, consider subscribing, and click the special offer link below.
Shares of TransMedics (TMDX) are falling after Scorpion Capital revealed its short position on the company Friday. The ...
周一,派杰桑德勒 (Piper Sandler)分析师Matt O'Brien维持对专注于器官移植技术的TransMedics Group (NASDAQ:TMDX)的"增持"评级和90.00美元的目标价。O'Brien的乐观态度基于该公司近期的表现指标,包括器官移植量和TransMedics医疗专机机队的活动。
TransMedics(TMDX)是一家在器官移植技术领域占据领先地位的公司,自2022年初至2024年中,该公司销售额连续10个财季增长超过100%。然而,最新一财季的收入增长率仅为64%,并且公司对于即将到来的第四财季下调了35%的增长预期,这使 ...
EST TransMedics (TMDX) down 10% to $65.39 after Scorpion Capital short reportStay Ahead of the Market:Discover outperforming stocks and ...
Shares of Transmedics (NASDAQ: TMDX) fell 28.1% in December, according to data from S&P Global Market Intelligence. On Dec. 2 ...
TransMedics is a commercial-stage medical technology company working on organ transplant therapy. Check out more about the ...
在其他近期新闻中,TransMedics Group的股票评级经历了多次变化。摩根大通将该医疗技术公司从增持下调至中性,并将目标价从之前的116美元下调至75美元。这一调整是由于2024年表现喜忧参半以及短期前景谨慎,尽管公司长期增长潜力显著。与此同时,Piper Sandler维持对该股票的增持评级,但将目标价从110.00美元调整至90.00美元。
2025年1月8日,医疗保健技术公司TransMedics Group(TMDX)成交额为2.47亿美元,在当日美股中排第307名,成交额较昨日减少18.07%,当日成交量为334.04万。 TransMedics Group(TMDX)于2025年1月8日跌7.78%,报72.55美元,该股过去5个交易日涨16.36%,整个1月涨16.36%,年初至今涨16.36%,过去52周跌15.33%。
Philadelphia, Pennsylvania-- (Newsfile Corp. - January 10, 2025) - Kehoe Law Firm, P.C. is investigating potential securities class action claims on behalf of investors of TransMedics Group, Inc.